Thanks to your generous donations, Neurocare was able to help fund the final year of a revolutionary three year project that was aimed at finding a better treatment for the brain cancer glioblastoma.

Brain tumours are responsible for the loss of 5,000 lives every year in the UK. Of these, glioblastoma is the most common and aggressive cancer arising from within the brain.

Current treatment methods involve surgery to remove as much of the tumour as safely possible, followed by chemotherapy and radiotherapy. In spite of this, sadly most people diagnosed with a glioblastoma will only survive between one to two years.

In 2019, we asked you to help support a pioneering research project led by Mr Ola Rominiyi at the University of Sheffield’s Department of Oncology & Metabolism. Ola and his team of researchers were able to explore new anti-cancer compounds alongside other drugs, that have shown to block cancer cells repairing and therefore surviving after damaging treatments such as Chemotherapy and Radiotherapy.

The team used part of the brain tumour taken away during surgery to grow 3D glioblastoma cells in the laboratory. This allowed the team to mimic the environment that is found in patients as closely as possible, to ensure the most accurate results and therefore faster progression into clinic.

Watch our original appeal video to find out more about the research that your donations helped to fund.